Hapten Sciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2021-08-27
- Lead Sponsor
- Hapten Sciences, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT04853823
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
- First Posted Date
- 2016-03-07
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Hapten Sciences, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02700373
- Locations
- 🇺🇸
Clinical Research Solutions, Franklin, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath